BCB
CELG

Brian C. Broderick’s Celgene Corp CELG Stock Holding History

Brian C. Broderick’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-2,280
Closed -$215K – 86
2019
Q1 		$215K Buy
+2,280
New +$199K 0.08% 78
2018
Q4 		– Sell
-21,574
Closed -$1.93M – 87
2018
Q3 		$1.93M Buy
21,574
+798
+4% +$70.5K 0.66% 46
2018
Q2 		$1.65M Buy
20,776
+6,590
+46% +$547K 0.6% 49
2018
Q1 		$1.26M Buy
14,186
+5,716
+67% +$549K 0.47% 52
2017
Q4 		$884K Buy
+8,470
New +$956K 0.32% 59

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Brian C. Broderick's CELG Position: Q2 2019 in Review

Brian C. Broderick sold out of Celgene Corp (CELG) in Q2 2019, closing a stake of 2,280 shares — an estimated $215K sold.

Brian C. Broderick first reported a position in CELG in Q4 2017 and held it in 5 quarters. The position peaked at $1.93M in Q3 2018. 1,287 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

  • Brian C. Broderick reported no remaining Celgene Corp position as of Q2 2019 after selling out during the quarter.
  • Brian C. Broderick sold 2,280 Celgene Corp shares in Q2 2019, an estimated $215K.
  • Brian C. Broderick first reported a position in Celgene Corp in Q4 2017 and held it in 5 quarters.
  • Brian C. Broderick's Celgene Corp position peaked at $1.93M in Q3 2018.
  • 1,287 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on Brian C. Broderick's 13F filing for Q2 2019, filed 24 Jul 2019.